Microsoft word - cv-06-20-2012

Mehrnoosh Hashemzadeh, Ph.D.


Education
Ph.D. Organic Synthetic Chemistry, University of Connecticut, Storrs, CT B.S., Chemistry, Shiraz University, Shiraz, Iran
Professional Experience

July. 2007-Present
Sarver Heart Center, Scientific member, University of Arizona, Tucson, AZ Assistant Professor of Chemistry, Whittier College Lecturer, University of California, Irvine Junior Specialist, University of California, Irvine Post-doctoral Researcher at University of California Irvine with Professor James S. Nowick Coordinator of Chemistry Outreach Program University of California at Irvine June. 1999-Oct. 2000 Graduate Student Researcher at University of University of Connecticut, Storrs, CT Aug. 1995-May 1998 Graduate Student Teaching Assistant at University of Connecticut
Teaching Experience

Sep.2005-Sep. 2006
Assistant Professor of Chemistry, Whittier College University of California Irvine Coordinator of UCI Chemistry Outreach Program • Organized and performed numerous demonstrations annually on the UCI campus for schools and in community requested by local schoolteachers. • Organized professional community science educational programs at. American Chemical Society, National Chemistry Week, KinderCaminata, Santa Ana Discovery Center, YMCA, Upward Bound, local science fairs, etc. Aug 1995- May 1998 University of Connecticut, Storrs, CT University of Connecticut, Storrs, CT English Instructor in International Teaching Assistant Program (ITAP)
Research Experience

Sep. 2007-Present University of Arizona, Tucson
Sep.2005-Dec. 2006
Nov 2000- Dec. 2003
University of California, Irvine - Irvine, CA Research:
1. Design of several molecules to induce apoptosis in treatment of atherosclerosis 2. Design of IL-18 protein binding receptor 3. Sub-Investigator- Trial TIMI-52 Solid. A Clinical Outcomes Study of Darapladib versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE). 4. Sub-Investigator- Cardiovascular outcomes study to evaluate the potential of aleglitazar to reduce cardiovascular risk in patients with a recent acute coronary syndrome (ACS) event and type 2 diabetes mellitus (T2D) ALECARDIO 5. Sub-Investigator- Evaluation of the Safety and Efficacy of Short-Term A-002 Treatment in Subjects with Acute 6. Sub-Investigator, Trial – IMPROVE-IT. A Multi-center, Double-Blind, Randomized Study to Establish the Clinical Benefit and Safety of Vytorin (Ezetimiber/Simvastatin Tablet) vs Simvastatin Monotherapy in High-Risk Subjects Presenting With Acute Coronary Syndrome (IMProved Reduction of Outcomes: Vytorin Efficacy International) 7. Sub-Investigator, A Randomized, Multicenter, Double-Blind, Group-Sequential Study to Evaluate the Efficacy, Immunogenicity, and Safety of a Single Dose of Merck 0657nl Staphylococcus aureus Vaccine (V710) in Adult Patients Scheduled for Cardiothoracic Surgery. 8. Sub-Investigator, A Phase II, multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of PROCHYMAL® (ex vivo cultured adult human mesenchymal stem cells) intravenous infusion following acute myocardial infarction. 9. Sub-Investigator-Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH530348 in Addition to Standard of Care in Subjects With a History of Atherosclerotic Disease: Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P - TIMI 50) P04737-3546 10. Sub-Investigator, Plato Trial, X6426 and SHC, The primary objective of this trial is to test the hypothesis that AZD6140 is superior to clopidogrel for the prevention of vascular events in patients with non-ST or ST elevation acute coronary syndromes (ACS). 11. Sub-Investigator, Lovaza, a randomized , double blind , placebo controlled, parallel- group Trial to assess the efficacy and safety of Omacor for the prevention of recurrent, symptomatic atrial fibrillation
Postdoctoral Research

• Design, synthesis and evaluation of peptidomimetics; targeting various diseases ranging from
AIDS to cancer to neurodegenerative (Huntington’s and Alzheimer’s disease).
• Designed and synthesized the first water folding b-sheet containing unnatural Hao amino acid.
• Designed and synthesized the peptidomimetics with metal binding sites, which induces b-sheet formation and allows
dimerizations via metal complexation.
• Devised novel synthetic routes to the various peptidomimetics.
• Determined b-sheet formation and b-sheet dimerization of peptidomimetics by NMR (1D, 2D, titration studies
• Built the first Hao-containing combinatorial library synthesized in the Nowick lab, and initiated on bead receptor and protein binding assays. • Designed and synthesized multivalent ligands, using dendrimers as template, to bind with the receptors.

Ph.D. Research,
• Synthetic methodology employing 2- methyleneoxetanes and 1, 5-dioxaspirohexanes as template
• Tandem reactions with electrophiles followed by nucleophile • Reductive ring opening with Li and DTBB. • Studies toward the total Synthesis of Plakoside A • Employment of Organometallic chemistry in natural product synthesis • Synthesis and physical studies of photoresponsive dendritic self-assembly
B.S. Research

• Synthesis of analogs of Cephalosporin

Skills:
• Clinical Trials
• Review and Submission of Investigator Initiated Study Protocols • Drug discovery, design and synthesis
Research Publications

1. Movahed MR, Ramaraj R, Manrique C, Hashemzadeh M.” Mitral annulus calcification is independently
associated with all-cause mortality” Experimental and Clinical Cardiology, 2012 in press
2. Movahed MR, Ramaraj R Hashemzadeh M, Khoynezhad, A, Hashemzadeh M. Declining in-hospital mortality in
patients undergoing coronary bypass surgery (CABG) in the United States irrespective of presence of type 2
diabetes or congestive heart failure, Clin Cardiol. 2012 Feb 23 in press
3. Arsanjani R. Khitri A, Hashemzadeh M, Movahed MR. Low dose unfractionated heparin administration during
intravascular ultrasound studies is safe even shortly after endomyocardial biopsy in cardiac transplant patients, J
Invasive Cardiol. 2012 ; 24(4):154-6
4. Movahed MR, Ramaraj R Hashemzadeh M, Khoynezhad, A, Hashemzadeh M. Declining in-hospital mortality in
patients undergoing coronary bypass surgery (CABG) in the United States irrespective of presence of type 2
diabetes or congestive heart failure, Clinical Cardiology, 2011 in press after revision
5. Hashemzadeh, M, Movahed, MR, Ramaraj, K."Novel Antiplatelet Agent Ticagrelor in The Management of Acute
Coronary Syndrome". J. Interventional Cardiology 2011, 24(3): 199-207
6. Hashemzadeh, M.; Movahed, M.R.; Russu, W.A.; Ladan Soroush, L.; Nizhoni Hill, D. “Novel Design and
Synthesis of Modified Structure of Carvedilol”. Recent Patent Cardiovasc Drug Discov. 2011; 6(3): 175-9.
7. Movahed MR, John J, Hashemzadeh M, Hashemzadeh M. Mortality Trends for Non ST Segment Elevation
Myocardial Infarction in the United States from 1988 to 2004, Clinical Cardiology, 2011, In press
8. Movahed MR, Ramaraj R, Hashemzadeh M, Hashemzadeh M. “Nationwide trends in the age adjusted prevalence
of non- ST elevation myocardial infarction (NSTEMI) across various races and gender in the United State”, Acute
Cardiac Care, 2010; 12 (2): 58-62
9. Hashemzadeh, M.; Hill, D. N.; Russu, W. "Comprehensive Review of b-Blockers from Chemistry to Clinical
Application" in preparation for Cardiovascular Pharmacology and therapeutics 10. Movahed MR, Hashemzadeh M, Khoynezhad, A, Jamal MM, Ramaraj R. Gender and race specifics nationwide
trends in the utilization of coronary bypass surgery (CABG) in the United States, J. Thorac. Cardiovasc. Surg.,
2010; 139:1545-1547
11. Movahed, M. R.; Ramaraj, R., Jamal, M.M., Hashemzadeh, M. , Hashemzadeh, M, "Nationwide trends in the age
adjusted incidence of non- ST elevation myocardial infarction (NSTEMI) across various races and gender" J. of
American Journal of Cardiology 2009, 1; 104(1): 5-8.
12. "Current Status of thoracic endografting and its adjunctive pharmacology"" Khoynezhad, A.; Movahed, M.R.; Hashemzadeh, M.; Emaminia, A.; Jalali, Z. J. Expert Opinion On Pharmacotherapy 2009, 10(17): 2871-81.
13. "Rate of acute ST-elevation myocardial infarction in the United States from 1988 to 2004 (from the Nationwide Inpatient Sample) ".Movahed MR, Ramaraj R, Hashemzadeh M, Jamal MM, Hashemzadeh M. Am J Cardiol. 2009
Jul 1; 104(1):5-8.
14. “Trends in the age adjusted mortality from acute ST segment elevation myocardial infarction in the United States (1988-2004) based on race, gender, infarct location and comorbidities.” Movahed MR, John J, Hashemzadeh M.,
Jamal MM. Hashemzadeh M. Am J Cardiol. 2009,15; 104(8): 1030-4
15. "Preoperative management of patients on adenosine diphosphate inhibitors in the era of drug-eluting stents: review of the literature and clinical implications" Khoynezhad, A.; Movahed, M.R.; Hashemzadeh, M.; Emaminia, A.;
Jalali, Z. J. Current Med Chem. 2009; 16(5): 591-8
16. “Antiplatelet Drugs, A Review" Hashemzadeh, M. Goldsberry S.; Furukawa, M. T.; Hill, D. N.; Movahed, M. R.
J. Invasive Cardiology 2009, 21, 8, 406-412 17. "Intravenous Glycoprotein IIb/IIIa Receptor Blockers: Chemical Structures and Mode of Action. A Review" Hashemzadeh, M.; Furukawam, M.; Goldsberry, S; Movahed, M.R. Experimental and Clinical Cardiology, 2008;
13(4): 192–197.
18. "Cyclic Modular b-Sheets" Woods, J. R.; Brower, J. O. Hashemzadeh, M.; Khakshoor, O.; Russu, W. A.; Nowick,
J.S. J. Am. Chem. Soc 2007, 129, 2548-58
19. "Cardiovascular and Hemodynamic Effect of Polyethylene Glycol in Rats" Samsamshariat, A.; Hashemzadeh, M.;
Samsamshariat, Z.; Movahed, M.R Cardiovascular Revascularization Medicine 2005, 6, 70-72.
20. "Study of Cardiovascular and its Hemodynamic Effects of PEG (Polyethylene Glycol) in Rat Model" Movahed, M.R., Samsamshariat, S.A.; Hashemzadeh, M. Chest 2004,126, (4): 826S.
21. "Design and Synthesis of the First Example of a Water Folding b-Sheet Containing the Unnatural Amino Acid Hao", Hashemzadeh, M; Nowick, J. S., Manuscript in preparation for J. Am. Chem. Soc.
22. "DSA: A New Internal Standard for NMR Studies in Aqueous Solutions" Nowick, J. S.; Khakshoor, O.; Hashemzadeh, M.; Brower, J. O. Org. Lett. 2003, 5, 3511-3513.
23. Synthesis of D-erythro-Dihydrosphingosine and D-xylo-Phytosphingosine from a Serine-Derived 1,5-Dioxaspiro [3.2] hexane Template Albert J. Ndakala, Hashemzadeh, M.; Regina C. So, and Amy R. Howell Org. Lett. 2002, 4
(10), 1719 –1722.
24. "Photoresponsive Langmuir monolayers from azobenzene-containing dendrons" Sidorenko, A.; Houphouet-Boigny, C.; Villavicencio, O.; Hashemzadeh, M.; McGrath, D. V.; Tsukruk, V. V.Langmuir 2000, 16(26), 10569-10572.
25. "Langmuir monolayers from azobenzene-containing dendrons" Sidorenko, A.; Houphouet-Boigny, C.; Greco, A. C.; Villavicencio, O.; Hashemzadeh, M.; McGrath, D. V.; Tsukruk, V. V. Polymer Preprint. 2000, 41(2), 1487-1488.
26. "Reductive Ring Opening of 2-Methyleneoxetanes" Hashemzadeh, M.; Howell, A. R. Tetrahedron. Lett. 2000, 41,
27. "An Unusual and Efficient Reaction of 2-Methylene-3-phenyloxetane under Reductive Ring Opening Conditions in THF" Hashemzadeh, M.; Howell, A.R. Tetrahedron. Lett. 2000, 41, 1859-1862.
28. "Preparation and Properties of 2-Methyleneoxetanes" Dollinger, L.; Ndakala, A.; Hashemzadeh, M.; Wang, G.;
Wang, Y; A.; Martinez, I.; Arcari, J.T.; Galluzzo, D.J.; Howell, A.R. J. Org. Chem. 1999, 64, 7074-7080.
29. "Toward Photoresponsive Dendritic Self- Assembly" Hashemzadeh, M.; McGrath, D.V. Polymer Preprint 1998,
30. "Driving Dendrimers with Light" McGrath, D.V.; Junge, D.; McElhanon, J.; Hashemzadeh, M. Polymer Preprint
1998, 281-282.

Research Presentations
1. Movahed MR, Hashemzadeh M, Hashemzadeh M. Gradual Decline In The Age Adjusted In-hospital Mortality
Rate From Cardiogenic Shock In The Setting of STEMI Irrespective Of Race With Persistent Higher Mortality Rate In African Americans, CRT 2012, Washington D/C, Feb 2012 2. Hashemzadeh M, Hashemzadeh M, Movahed MR. Gradual decline in the Age Adjusted Mortality Rate from
Cardiogenic Shock of any Cause irrespective of gender accepted for poster presentation at 2012 ASA Conference on Statistical Practice, Florida 3. Movahed MR, Hashemzadeh M, Hashemzadeh M. G Gradual Decline In The Age Adjusted In-hospital Mortality
Rate From STEMI Related Cardiogenic Shock Irrespective of Gender With Persistent Higher Mortality Rate In Women. CRT 2012, Washington D/C, Feb 2012 4. Movahed MR, Hashemzadeh M, Hashemzadeh M. Decline in the age adjusted in-hospital mortality rate from
STEMI related cardiogenic Shock irrespective of gender with persistent higher mortality rate in women. Poster presentation at American Colleague of Cardiology Scientific Session, 2012, Chicago, J Am Coll Cardiol, Supp, March 2012 5. Movahed MR, Hashemzadeh M, Hashemzadeh M Gradual decline in the in-hospital mortality of type 2 diabetes
patients presenting with acute ST segment elevation myocardial infarction over last 20 years presented at the SCAI
2012 Scientific Sessions in Las Vegas, NV May 9-12, 2012. Catheter Cardiovasc Interv.May;79(6)(Suppl): A050
6. Movahed MR, Hashemzadeh M, Habibzadeh R, Khan M, Hashemzadeh M . In-hospital mortality of obese patients
undergoing percutaneous coronary intervention has been declining from 1989 to 2006 presented at the SCAI 2012 Scientific Sessions in Las Vegas, NV May 9-12, 2012. Catheter Cardiovasc Interv.May;79(6)(Suppl): B046 7. Movahed MR, Hashemzadeh M, Khan M, Habibzadeh R, Hashemzadeh M . Gradual decline in in-hospital
mortality of patients undergoing percutaneous coronary intervention in diabetes and non-diabetes patients presented at the SCAI 2012 Scientific Sessions in Las Vegas, NV May 9-12, 2012. Catheter Cardiovasc Interv.May;79(6)(Suppl): C035 8. Movahed MR, Hashemzadeh M, Hashemzadeh M . “Decline in the In-hospital Motality of Type 2 Diabetes
patients with a Acute ST Segment Elevation Myocardial Infarction " accepted for presentation at the International Academy of Cardiology, 17th World Congress on Heart Disease, Annual Scientific Sessions 2012,to be held in Toronto, ON, Canada, July 27 - 30, 2012. 9. Movahed MR, Hashemzadeh M, Hashemzadeh M . IN-HOSPITALMORTALITY OF OBESE PATIENTS
UNDERGOING PERCUTANEOUS CORONARY INTERVENTION HAS BEEN DECLINING FROM 1994 TO 2006" accepted for presentation at the International Academy of Cardiology, 17th World Congress on Heart Disease, Annual Scientific Sessions 2012,to be held in Toronto, ON, Canada, July 27 - 30, 2012. 10. Movahed MR, Hashemzadeh M, Hashemzadeh M . GRADUAL DECLINE IN IN-HOSPITAL MORTALITY OF
PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN DIABETES AND NON-DIABETES PATIENTS" accepted for presentation at the International Academy of Cardiology, 17th World Congress on Heart Disease, Annual Scientific Sessions 2012,to be held in Toronto, ON, Canada, July 27 - 30, 2012. 11. Movahed MR, Hashemzadeh M, Habibzadeh, M, Hashemzadeh M. No Reduction in the Age Adjusted Nationwide
Trends in the Incidence of Cardiogenic Shock in the United State Irrespective of Gender or Ethnicities, Poster
presentation at TCT 2011.
12. Movahed MR, Hashemzadeh M, Habibzadeh, M, Hashemzadeh M. Gradual decline in the Age Adjusted Mortality
Rate from Cardiogenic Shock of any Cause or in the Setting of ST Elevation Myocardial Infarction in the United
State. Poster presentation at TCT 2011.
13. Arsanjani R, Khitri A, Hashemzadeh M, Movahed MR. Detection of > 0.4 mm of Minimal Intimal Thickness
During Routine Intracoronary Ultrasound Studies Without a Baseline Study Correlates strongly with Total Death
and Adverse Outcomes in Cardiac Transplant Patients. Poster presentation at TCT 2011.
14. Movahed MR, Hashemzadeh M, Habibzadeh, M, Hashemzadeh M. Gradual reduction in the age adjusted
nationwide trends in the incidence of cardiogenic shock occurring in the setting of ST elevation myocardial
infarction across different ethnicities and gender in the United State. Poster presentation at TCT 2011.
15. Movahed MR, Hashemzadeh M, Hashemzadeh M. OBESITY IS STRONGLY ASSOCIATED WITH PRESENCE
OF PULMONARY EMBOLISM presented as poster at 16 International Academy of Cardiology World Congress on
Heart Disease Annual Scientific Sessions 2011, Vancouver, BC, Canada, July 25, 2011, Journal of Heart Disease
16. Arsanjani R, Khitri A, Hashemzadeh M, Movahed MR. "Safe administration of Low Dose Heparin Administration
During Routine IVUS Studies Without Therapeutic Coronary Intervention After Endomyocardial Biopsy" Accepted
for poster presentation at 15th world congress on heart disease, the International academy of cardiology annual
scientific sessions, Vancouver, Canada, July, 2010, The Journal of Heart Disease
17. Arsanjani R, Khitri A, Hashemzadeh M, Movahed MR. "Safe use of Protamine For Heparin Reversal Following
Routine Intravascular Ultrasound Studies In Cardiac Transplant Patients Without Any Adverse Reaction. Accepted
for poster presentation at 15th world congress on heart disease, the International academy of cardiology annual
scientific sessions, Vancouver, Canada, July, 2010, The Journal of Heart Disease
18. Arsanjani R, Khitri A, Hashemzadeh M, Movahed MR. " Serial Intravascular Ultrasound in the Evaluation of
Cardiac Transplant Vasculopathy" Accepted for poster presentation at 15th world congress on heart disease, the
International academy of cardiology annual scientific sessions, Vancouver, Canada, July, 2010, The Journal of
Heart Disease
19. Movahed MR, Hashemzadeh M, Habibzadeh, M.R. Hashemzadeh M. Lower Trend in the Nationwide In-hospital
Mortality of Patients Undergoing Coronary Bypass Surgery (CABG) in the United Stated. Accepted for poster
presentation at 15th world congress on heart disease, the International academy of cardiology annual scientific
sessions, Vancouver, Canada, July, 2010, The Journal of Heart Disease
20. Arsanjani R, Khitri A, Hashemzadeh M, Movahed MR. "Low Dose Heparin Administration During Routine IVUS
Studies Without Therapeutic Coronary Intervention Is Safe Even Shortly After Endomyocardial Biopsy" Accepted
for presentation at Society of Cardiovascular Angiography and Intervention convention (SCAI), May 2010
21. Arsanjani R, Khitri A, Hashemzadeh M, Movahed MR. "Protamine Can Safely Be Administered For Heparin
Reversal Following Routine Intravascular Ultrasound Studies In Cardiac Transplant Patients Without Any Adverse Reaction. Accepted for presentation at Society of Cardiovascular Angiography and Intervention convention (SCAI),
May 2010
22. Arsanjani R, Khitri A, Hashemzadeh M, Movahed MR. "Utilization of Serial Intravascular Ultrasound in the
Evaluation of Cardiac Transplant Vasculopathy" accepted for presentation at Society of Cardiovascular
Angiography and Intervention convention (SCAI), May 2010
23. Arsanjani R, Khitri A, Hashemzadeh M, Movahed MR. "Low Dose Heparin Administration During Routine IVUS
Studies Without Therapeutic Coronary Intervention Is Safe Even Shortly After Endomyocardial Biopsy" presented
as POSTER at CRT 2010, February, 21, 2010
24. Arsanjani R, Khitri A, Hashemzadeh M, Movahed MR. "Protamine Can Safely Be Administered For Heparin
Reversal Following Routine Intravascular Ultrasound Studies In Cardiac Transplant Patients Without Any Adverse
Reaction" presented as POSTER at CRT 2010, February, 21, 2010
25. Khitri A, Arsanjani R. Hashemzadeh M, Movahed MR. "Utilization of Serial Intravascular Ultrasound in the
Evaluation of Cardiac Transplant Vasculopathy" presented as POSTER at CRT 2010, February, 21, 2010
26. Movahed MR, John J, Jamal M, Hashemzadeh M, Hashemzadeh M. Significant decline in the age adjusted
mortality from ST segment elevation myocardial infarction in the United state regardless of race or gender with
persistent higher mortality rate for female and African American population, Presented as oral presentation at the
American Heart association November 16, 2009, Circulation Supplement 2009
27. Movahed MR, Hashemzadeh, M, Ramaraj R. Increase in the nationwide utilization of percutaneous coronary
intervention (PCI) in patients with diabetes, congestive heart failure, ST elevation and non St elevation myocardial infarction in the United State, Presented at TCT congress, San Francisco, CA, Am J Cardiol. 2008;(supp) 104 (6): 549 September 2009 28. AEI: b-Hairpin peptides containing a novel b-turn mimic and an unnatural amino acid that mimics a peptide b- strand. Hashemzadeh, M.; Nowick, J. S. Abstracts of Papers, 2004, 228th ACS National Meeting, Philadelphia,
PA, August 22-26.
29. DSA: “A new internal standard for NMR studies of cationic peptides”. Nowick, J. S.; Khakshoor, O.; Hashemzadeh, M.; Brower, J. O. Abstracts of Papers, 2004, 227th ACS National Meeting, Anaheim, CA, March
28-April 1.
30. Cyclic modular b-sheets. Woods, R. J.; Brower, J. O.; Gothard, C. M.; Hashemzadeh, M.; Khakshoor, O.; Russu,
W. A.; Nowick, J. S. Abstracts of Papers, 2004, 227th ACS National Meeting, Anaheim, CA, March 28-April 1,
31. Right ventricular infarction after ligation of mid left anterior descending artery in rats. Samsamshariat, S.A.; Hashemzadeh, M.; Movahed, MR, presentation at CRT, May 2004, Washington, DC.
32. A Novel method of left anterior descending artery ligation in rats with very high success rate. Samsamshariat, S.A.; Hashemzadeh, M., Movahed, M.R poster presentation at CRT, May 2004, Washington, DC.
33. "Design and Synthesis of a b-Sheet Model Containing Unnatural Amino Acid HAO that Folds in Aqueous Solution". Hashemzadeh, M.; Nowick, J.S. 8th International Symposium of Solid Phase Synthesis and
Combinatorial Chemical libraries in London September 2-6th 2003.
34. "3-Amino-1, 5-Dioxaspiro [3.2] hexanes: Templates for the synthesis of biologically important a-galactosyl ceramides" Howell, A my R.; Ndakala, Albert J.; Hashemzadeh, M.; So, Regina C. Abstr. Pap. - Am. Chem. Soc.
Presentation at Spring National A.C.S. Meeting, San Diego, CA 2001, 221st.
35. "Langmuir monolayers from azobenzene-containing dendrons" Sidorenko, A.; Houphouet-Boigny, C.; Greco, A. C.; Villavicencio, O.; Hashemzadeh, M.; McGrath, D. V.; Tsukruk, V. V. Abstr. Pap. - Am. Chem. Soc. Presented at
Fall National A.C.S. Meeting, Washington DC, MD 2000, 220th.
36. "Reductive ring opening of 2-methyleneoxetanes" Durgin, M.; Hashemzadeh, M.; Howell, Amy R. Abstr. Pap. -
Am. Chem. Soc. Presented at Fall National A.C.S. Meeting, Washington DC, MD 2000, 220th.
37. "A versatile Synthesis of Sphingolipids via Ring Opening of 3-Amino-1, 5-dioxaspirohexanes Using Organometallic Reagents "Hashemzadeh, M.; Howell, A. R. Oral presentation at NERM (Northeast Regional Meeting of the
American Chemical Society), University of Connecticut, June 2000.
38. "Ring Opening of 1,5-Dioxaspirohexanes with Organometallic Reagents-A new Strategy to Sphingoid Bases" Hashemzadeh, M.; Howell, A. R. Poster presented at the Randolph T. Major Memorial Lecture Symposium,
University of Connecticut, April 2000
39. "A Novel Route to Sphingolipids Via Ring Opening of 1,5-Dioxaspirohexanes Utilizing Organometallic Reagents” Hashemzadeh, M.; Howell, A. R. presented at the Spring National A.C.S. Meeting, San Francisco, CA 2000.
40. "Enolate Dianions via Reductive Ring Opening of 2-Methyleneoxetanes" Hashemzadeh, M.; Howell, A.R. Abstr.
Pap. - Am. Chem. Soc. presented at the Fall National A.C.S. Meeting, New Orleans, LA 1999.
41. "Toward Photoresponsive Self-Assembly" Hashemzadeh, M.; McGrath, D.V. Abstr. Pap. - Am. Chem. Soc.
presented at the Fall National A.C.S. Meeting, Boston, and MA 1998.
42. "Synthesis and Studies of Physical Properties of Photoresponsive Dendritic Self-assembly Structures" Hashemzadeh, M.; McGrath, D.V. Poster presented at the Randolph T. Major Memorial Lecture Symposium,
University of Connecticut, October 1998.
Affiliation

 Scientific member of Sarver Heart Center, University of Arizona
 SC Advisory Board of GlaxoSmithKline  Member of AAPS (American Association of Pharmaceutical Science)  American Chemical Society (Organic Chemistry division)  American Chemical Society (Medicinal Chemistry division)  Honorary member of Phi Lambda Upsilon American Chemical Society  Member of ICA-ACS (Iranian Chemists Association of American Chemical Society)  Member of NIPOC (Network of Iranian Professional of Orange County)  Member of AWIS (American Women in Science)  CEO and Director of Medicinal Chemistry at Sina Pharmaceuticals  Reviewer of Journal of Chemical Education  Grant Peer Reviewer for the American Heart Association, May 2010-present
Honors/ Awards

University of Connecticut, Storrs, CT
 Extraordinary graduate student award August 2000  Doctoral Dissertation fellowship award June 2000  Chairman's fellowship, 1999
 Shiraz University, Shiraz, Iran, 1994
 An award for excellence as an undergraduate student  Ranked among the top 2 % in undergraduate program Shiraz University, Shiraz, Iran, 1993
 A Senior award for outstanding research in the last 2 years of undergraduate program

Source: http://congress.iranathero.ir/UserFiles/file/CV/CV-06-20-2012.pdf